AI주식인사이트AI Stock Insight
A

휴온스

243070KOSDAQ

70.6 / 100

Reference Date: 2026-09-08

Financial Score30.0 / 40
News Sentiment19.6 / 25
Momentum7.0 / 20
Disclosure14.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health but Operating Profit is on a declining trend. Plunged 20.7% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

Hoonswell, established in 1965, is a pharmaceutical company operating in specialty drugs, beauty & wellness, and contract manufacturing (CMO). Key products include local anesthetics, functional food supplements, and medical devices, with exports to the U.S. via FDA approval. The company expanded its global presence by launching its second plant in Cheongju in 2024.

Number of Employees

1,087people

Average Salary

58.0M KRW

Score Calculation Basis

Detailed Financial Score

PER
5.98Industry Average 15.008.0Point

Half of industry avg (excellent)

PBR
0.61Industry Average 1.205.5Point

Lower than industry avg (good)

ROE
11.04Industry Average 8.004.0Point

In line with industry avg

Debt Ratio
22.82Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20254.5 / 10 points
Revenue Growth Rate
2.0 / 3

Avg ▲6.0% (2-year basis)

Operating Profit Growth Rate
0.0 / 3

Avg ▼7.1% (2-year basis)

ROE Trend
2.5 / 4

Avg ROE 12.0% (declining, 3yr)

Detailed News Sentiment

17 totalPositive 14Neutral 2Negative 1Average Sentiment Score 78.5

Detailed Momentum

52-week position1.0Point

Near 52w low (1%, downtrend)

Current 21,100Won52-week high 38,20052-week low 20,900
1-month return0.0Point

1m -20.68% (strong drop)

Volume trend6.0Point

Volume surge

Detailed Disclosure

8 totalPositive 2Neutral 6Negative 0
  • Neutral기타주요경영사항 (회사합병 결정 및 임시주주총회 소집결의 철회)2026-08-26
  • Neutral[기재정정]주요사항보고서(회사합병결정)2026-08-26
  • Neutral[기재정정]주주총회소집결의 (임시주주총회-철회)2026-08-26
  • Neutral기업설명회(IR)개최2026-08-24
  • Neutral반기보고서 (2026.06)2026-08-14